Search results for: Coronary Heart Disease
Filter search results
Chronic Diseases and the Stock of Health: Quantification Using EQ-5D-5L
15 October 2019
…diseases and, second, rank diseases according to their impact on the stock of health for a country. The impact of chronic diseases is difficult to measure, with no consensus on…
Disease severity and public preferences
4 November 2010
…made by others’. The study results showed, first, that naming the disease did not increase the preference for treating the severe disease at the expense of the moderate disease and, second,…
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
…billion dollars are spent annually on managing non-communicable diseases, such as diabetes, heart disease, and cancer. These diseases are largely preventable, and often linked to environmental factors, such as air…
Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making
1 March 2010
In 2009, the English NHS began collecting patient-reported outcome measures (PROMs) for four elective procedures. Using a series of structured questions that ask patients about their health from their point…
The changing role of the NHS over time
14 August 2023
…disease, showing the top cause of death by gender and age group over time. Today, the leading cause of death for males is heart disease (13.3% of all male deaths),…
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
29 November 2023
…and as a result, diseases that are best treated by small molecules – like cancer and neurological disease – may be impacted most. In addition, certain disease areas that primarily…
Parkinson’s Disease
1 October 1991
…in the history of knowledge and treatment of Parkinson’s disease.’ Parkinson’s disease is a progressive, degenerative condition of the central nervous system which produces three main symptoms: tremor (shaking of…
Organ Transplantation
1 July 1991
…quality of life after transplantation are constantly improving. Cyclosporin has been credited with huge improvements in kidney transplantation and the transition of heart and liver transplants from experimental to effective…
Using MCDA to Assess the Value of Treatments for Rare Diseases
5 December 2013
…effects for rare diseases than for other diseases. Payers recognise that a different approach may be needed to determine reimbursement eligibility and levels for rare disease treatments. To explore one…